ResearcherFirst Affiliated Hospital of Soochow UniversityActive in the last 2 years
Bin Yi
Matched on ORCID iD 0000-0002-9239-8639; OpenAlex author ID A5081659458. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2021: 2 papers · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- SERTAD4-AS1 suppresses pancreatic cancer progression by stabilizing SERTAD4 and inhibiting the Notch1 pathway. Co-author DOI 10.1016/j.gendis.2025.101870↗
- RhoGDI2 induced malignant phenotypes of pancreatic cancer cells via regulating Snail expression. Co-author DOI 10.1007/s13258-022-01217-0↗
- Development and validation of a tissue-based DNA methylation risk-score model to predict the prognosis of surgically resected pancreatic cancer patients. Co-author DOI 10.21037/gs-22-517↗
- Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.682969↗
- Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis. Co-author DOI 10.7150/jca.48661↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuchen Tang · 5 shared papers, 2021–2026 · strength 0.83
- Paper SERTAD4-AS1 suppresses pancreatic cancer progression by stabilizing SERTAD4 and inhibiting the Notch1 pathway. DOI 10.1016/j.gendis.2025.101870↗
- Paper Development and validation of a tissue-based DNA methylation risk-score model to predict the prognosis of surgically re… DOI 10.21037/gs-22-517↗
- Paper RhoGDI2 induced malignant phenotypes of pancreatic cancer cells via regulating Snail expression. DOI 10.1007/s13258-022-01217-0↗
- Jian Zhou · 4 shared papers, 2021–2026 · strength 0.67
- Paper SERTAD4-AS1 suppresses pancreatic cancer progression by stabilizing SERTAD4 and inhibiting the Notch1 pathway. DOI 10.1016/j.gendis.2025.101870↗
- Paper RhoGDI2 induced malignant phenotypes of pancreatic cancer cells via regulating Snail expression. DOI 10.1007/s13258-022-01217-0↗
- Paper Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis. DOI 10.7150/jca.48661↗
- Haoran Li · 3 shared papers, 2021–2026 · strength 0.57
- Paper SERTAD4-AS1 suppresses pancreatic cancer progression by stabilizing SERTAD4 and inhibiting the Notch1 pathway. DOI 10.1016/j.gendis.2025.101870↗
- Paper Development and validation of a tissue-based DNA methylation risk-score model to predict the prognosis of surgically re… DOI 10.21037/gs-22-517↗
- Paper Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of … DOI 10.3389/fonc.2021.682969↗
- Jian Yang · 2 shared papers, 2022–2026 · strength 0.45
- Paper SERTAD4-AS1 suppresses pancreatic cancer progression by stabilizing SERTAD4 and inhibiting the Notch1 pathway. DOI 10.1016/j.gendis.2025.101870↗
- Paper Development and validation of a tissue-based DNA methylation risk-score model to predict the prognosis of surgically re… DOI 10.21037/gs-22-517↗
- Zixiang Zhang · 3 shared papers, 2021–2022 · strength 0.42
- Paper Development and validation of a tissue-based DNA methylation risk-score model to predict the prognosis of surgically re… DOI 10.21037/gs-22-517↗
- Paper RhoGDI2 induced malignant phenotypes of pancreatic cancer cells via regulating Snail expression. DOI 10.1007/s13258-022-01217-0↗
- Paper Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis. DOI 10.7150/jca.48661↗
- Yijun Wei · 2 shared papers, 2021–2026 · strength 0.42
- Jun Yao · 1 shared paper, 2026 · strength 0.29
- Ye Li · 2 shared papers, 2021–2022 · strength 0.28
- Paper Development and validation of a tissue-based DNA methylation risk-score model to predict the prognosis of surgically re… DOI 10.21037/gs-22-517↗
- Paper Development and Validation of a Nomogram Based on Nutritional Indicators and Tumor Markers for Prognosis Prediction of … DOI 10.3389/fonc.2021.682969↗
- Dechun Li · 2 shared papers, 2021–2022 · strength 0.26
- Jun Yao · 2 shared papers, 2021–2022 · strength 0.26
- Jian Yang · 2 shared papers, 2021–2022 · strength 0.26
- Dongming Zhu · 2 shared papers, 2021–2022 · strength 0.26
- Yujie Huang · 2 shared papers, 2021–2022 · strength 0.26
- Jie Wang · 1 shared paper, 2022 · strength 0.16
- Qiuhua Liu · 1 shared paper, 2022 · strength 0.13
- Yi Zhang · 1 shared paper, 2022 · strength 0.13
- Peng Du · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.